Prognostic Stratification of Initial Treatments for Hepatocellular Carcinoma Using a Modified Borderline Resectable Classification
Other than for patients with EHM, aggressive surgical resection may be considered a potential initial therapeutic option for advanced HCC; however, direct comparisons with other treatment modalities were not performed in this study.
Authors
- Kei Onishi (ORCID: https://orcid.org/0009-0002-0976-2979)
- Toru Usui (ORCID: https://orcid.org/0000-0002-9536-9868)
- Kozue Kanemitsu‐Okada (ORCID: https://orcid.org/0009-0005-6488-9616)
- Hideko Ohama (ORCID: https://orcid.org/0000-0002-1882-824X)
- Shogo Kitahata (ORCID: https://orcid.org/0000-0003-2133-6569)
- Naho Ishimura
- Eiji Tsubouchi (ORCID: https://orcid.org/0009-0000-0669-4398)
- Yoichi Hiasa (ORCID: https://orcid.org/0000-0003-4117-339X)
- Teruki Miyake (ORCID: https://orcid.org/0000-0002-9905-5356)
- Atsushi Hiraoka (ORCID: https://orcid.org/0000-0003-1989-0480)
- Kanako Kato
- Masashi Hirooka (ORCID: https://orcid.org/0000-0001-5634-5313)
- Hideki Miyata (ORCID: https://orcid.org/0000-0003-4883-0970)
- Masanori Abe (ORCID: https://orcid.org/0000-0003-4489-9102)
- Tomoe Kawamura (ORCID: https://orcid.org/0000-0001-6678-8724)
- Mai Saito
- Fujimasa Tada (ORCID: https://orcid.org/0009-0007-3964-5876)
- Jota Watanabe (ORCID: https://orcid.org/0000-0003-0717-2799)
- Tomoyuki Ninomiya (ORCID: https://orcid.org/0000-0002-9949-0446)
- Osamu Yoshida (ORCID: https://orcid.org/0000-0002-5015-0045)
- Hiromi Ohtani
- Ayaka Nakamura (ORCID: https://orcid.org/0009-0001-3743-8159)
- Taira Kuroda (ORCID: https://orcid.org/0009-0002-1397-1714)
- Yuka Kimura (ORCID: https://orcid.org/0009-0001-6392-6770)
- Jun Hanaoka (ORCID: https://orcid.org/0009-0001-0851-8192)
Institutions
- Ehime Prefectural Central Hospital (JP)
- Ehime University (JP)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/cam4.71470
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development